Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015

Tumor necrosis factor-α (TNF-α) inhibitors are increasingly being used as treatment for rheumatoid arthritis (RA). However, the administration of these drugs carries the risk of inducing injection site reaction (ISR). ISR gives rise to patient stress, nervousness, and a decrease in quality of life (...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Int J Med Sci
Κύριοι συγγραφείς: Matsui, Toshinobu, Umetsu, Ryogo, Kato, Yamato, Hane, Yuuki, Sasaoka, Sayaka, Motooka, Yumi, Hatahira, Haruna, Abe, Junko, Fukuda, Akiho, Naganuma, Misa, Kinosada, Yasutomi, Nakamura, Mitsuhiro
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Ivyspring International Publisher 2017
Θέματα:
Research Paper
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5332837/
https://ncbi.nlm.nih.gov/pubmed/28260984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.17025
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια